Selected article for: "body weight and recovery period"
Author: Riede, O; Seifert, K; Oswald, D; Endmann, A; Hock, C; Winkler, A; Salguero, F J; Schroff, M; Croft, S L; Juhls, C
Title: Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine
  • Document date: 2015_4_30
    • ID: 4eyn7pjq_29
    Snippet: Animals were observed for clinical signs including injection site reactogenicity before and 30 min and 4 h after each dosing and daily between injections. Mortality was evaluated twice daily throughout the study. Body weight of animals was recorded at day of group allocation, on the day of first dosing and three times a week thereafter. Food consumption was determined weekly and water consumption was recorded daily. Neurological screening 40 and .....
    Document: Animals were observed for clinical signs including injection site reactogenicity before and 30 min and 4 h after each dosing and daily between injections. Mortality was evaluated twice daily throughout the study. Body weight of animals was recorded at day of group allocation, on the day of first dosing and three times a week thereafter. Food consumption was determined weekly and water consumption was recorded daily. Neurological screening 40 and assessment of grip strength 41 was conducted on all animals 24 h after first dosing. Ophthalmological and auditory examinations were performed pre-dose, at the end of the treatment period and at the end of the recovery period.

    Search related documents:
    Co phrase search for related documents
    • animal conduct and body weight: 1, 2
    • body weight and clinical sign: 1, 2, 3, 4
    • body weight and food consumption: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • body weight and grip strength: 1, 2, 3
    • body weight and group allocation: 1, 2, 3
    • body weight and injection site: 1, 2
    • body weight and recovery period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • dosing day and injection site: 1
    • food consumption and recovery period: 1, 2, 3, 4
    • grip strength and group allocation: 1
    • group allocation and injection site: 1, 2, 3
    • injection site and recovery period: 1